FOXO TECHNOLOGIES INC. Investment Income, Investment Expense
FOXO TECHNOLOGIES INC. (FOXO) reported Investment Income, Investment Expense of $301.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-06-28.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInvestmentExpense · last filed 2024-06-28
- FOXO TECHNOLOGIES INC. investment income, investment expense for the quarter ending 2024-03-31 was $301.00K, a 33.78% increase year-over-year.
- FOXO TECHNOLOGIES INC. investment income, investment expense for the quarter ending 2023-03-31 was $225.00K.
- FOXO TECHNOLOGIES INC. investment income, investment expense for fiscal 2023 was $1.06M, a 26.11% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. investment income, investment expense for fiscal 2022 was $1.44M.
| Period end | Investment Income, Investment Expense 3 month | Investment Income, Investment Expense 12 month |
|---|---|---|
| 2024-03-31 | $301.00K 10-Q · filed 2024-06-28 | |
| 2023-12-31 | $1.06M 10-K · filed 2024-06-06 | |
| 2023-03-31 | $225.00K 10-Q · filed 2024-06-28 | |
| 2022-12-31 | $1.44M 10-K · filed 2024-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |